Shahinaz Faisal Bashir Bashir Mohamed

Dr. Shahinaz Faisal Bashir Bashir Mohamed

orcid

Research Focus & Metrics

Academic Career Length

5Years (2022-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 August 2022 in Journal of Epidemiology and Global Health
Verified
Journal Article
Open access
PDF file
GAGasmelseed Y. Ahmed
Gasmelseed Y. Ahmed
AMAbbas Al Mutair
Abbas Al Mutair
Shahinaz Faisal Bashir Bashir MohamedShahinaz Faisal Bashir Bashir Mohamed
Shahinaz Faisal Bashir Bashir Mohamed
RARommel Acunin
Rommel Acunin
NANora Al Aljabr
Nora Al Aljabr
EAEman Almusalami
Eman Almusalami
Background: Screening is a cancer prevention measure for groups who are asymptomatic, and diagnosis is a medical test for groups who are symptomatic. The occupational privilege of health care providers (HCPs) is expected to play a positive role in cancer screening practices. Therefore, this study aimed to assess perceptions and personal attitudes of HCPs regarding their decision to screen for cancer in the Eastern Province of Saudi Arabia. Design: A cross-sectional multicenter survey study was conducted. A well-designed and validated questionnaire was distributed to the HCPs at three tertiary hospitals in the Eastern Province of Saudi Arabia. Results: Out of 900 health care providers who received the questionnaire, 372 completed it. Two-thirds, 247 (66.4%) of them were nurses and the rest were physicians and the mean age was 34.1 ± 7.1 years. Regardless of gender, profession, or age, the overall rate of belief in the importance of regular cancer screening was high; 91.4%. The number of participants who did not screen for colonoscopy was significantly higher than those who screened. The number of females in the age group of between 45 and 54 years who screened with mammography was significantly higher than non-screened. In a similar way, male HCPs above 54 years who got themselves screened for Prostate-Specific Antigen (PSA) were significantly higher than those who did not. Conclusions: Findings of the current research and existing evidence specifically for the Saudi community indicated a need to raise awareness, emphasizing the role of HCPs in motivating themselves, their families, and their patients to implement various cancer screening programs.

6 January 2023 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
Ahmed BakillahAhmed Bakillah
Ahmed Bakillah
KKKhamis Khamees Obeid Khamees
Khamis Khamees Obeid Khamees
MSMaram Al Subaiee
Maram Al Subaiee
ASAyman Farouk Soliman
Ayman Farouk Soliman
MAMohammad Al Arab
Mohammad Al Arab
AQAli Ahmed Al Qarni
Ali Ahmed Al Qarni
Plasma lipoproteins exist as several subpopulations with distinct particle number and size that are not fully reflected in the conventional lipid panel. In this study, we sought to quantify lipoprotein subpopulations in patients with type 2 diabetes mellitus (T2DM) to determine whether specific lipoprotein subpopulations are associated with insulin resistance and inflammation markers. The study included 57 patients with T2DM (age, 61.14 ± 9.99 years; HbA1c, 8.66 ± 1.60%; mean body mass index, 35.15 ± 6.65 kg/m2). Plasma lipoprotein particles number and size were determined by nuclear magnetic resonance spectroscopy. Associations of different lipoprotein subpopulations with lipoprotein insulin resistance (LPIR) score and glycoprotein acetylation (GlycA) were assessed using multi-regression analysis. In stepwise regression analysis, VLDL and HDL large particle number and size showed the strongest associations with LPIR (R2 = 0.960; p = 0.0001), whereas the concentrations of the small VLDL and HDL particles were associated with GlycA (R2 = 0.190; p = 0.008 and p = 0.049, respectively). In adjusted multi-regression analysis, small and large VLDL particles and all sizes of lipoproteins independently predicted LPIR, whereas only the number of small LDL particles predicted GlycA. Conventional markers HbA1c and Hs-CRP did not exhibit any significant association with lipoprotein subpopulations. Our data suggest that monitoring insulin resistance-induced changes in lipoprotein subpopulations in T2DM might help to identify novel biomarkers that can be useful for effective clinical intervention.

Verified
Journal Article
Open access
PDF file
Ahmed BakillahAhmed Bakillah
Ahmed Bakillah
MSMaram Al Subaiee
Maram Al Subaiee
ASAyman Farouk Soliman
Ayman Farouk Soliman
KKKhamis Khamees Obeid Khamees
Khamis Khamees Obeid Khamees
Shahinaz Faisal Bashir Bashir MohamedShahinaz Faisal Bashir Bashir Mohamed
Shahinaz Faisal Bashir Bashir Mohamed
AQAli Ahmed Al Qarni
Ali Ahmed Al Qarni
Atrial natriuretic peptide (ANP) and oxidized low-density lipoprotein (ox-LDL) play essential roles in the development and progression of vascular complications associated with type 2 diabetes mellitus (T2DM), and both are independently linked to cardiovascular diseases (CVD). However, the relationship between ANP and ox-LDL in patients with T2DM remains unclear as previous studies have primarily focused on circulating levels in various diseases. This study investigated the relationship between ANP and ox-LDL levels in obese individuals with T2DM. The cohort included 57 patients with T2DM (mean age 61.14 ± 9.99 years; HbA1c 8.66 ± 1.60%; BMI 35.15 ± 6.65 kg/m2). Notably, 95% of the patients had hypertension, 82% had dyslipidemia, 59% had an estimated glomerular filtration rate (eGFR) < 60 mL/min/1.73 m2, 14% had coronary artery disease (CAD), and 5% had a history of stroke. Plasma concentrations of ANP and ox-LDL were measured using ELISA. Adipokines and cytokines levels were measured using the multiplex® MAP Human Adipokine Magnetic Beads Spearman’s correlation analysis which revealed a negative correlation between ANP and ox-LDL (r = −0.446, p = 0.001) as well as with the ox-LDL/apoB ratio (r = −0.423, p = 0.001) and ox-LDL/LDLc ratio (r = −0.307, p = 0.038). Multivariable regression analysis indicated that ANP was independently associated with ox-LDL (β = −115.736, p = 0.005). Stepwise linear regression further identified TNFα, leptin, and adiponectin as the strongest predictors influencing the relationship between ANP and ox-LDL levels (β = −64.664, p = 0.0311, and r2 = 0.546 for the model). However, these factors did not significantly mediate this association. This study emphasizes the need for further exploration of the complex interaction between ANP and ox-LDL in larger patient populations. This could provide valuable insights into potential therapeutic approaches for managing vascular complications in obese individuals with T2DM.

18 May 2026 in Preprints.org
Verified
Preprint
Open access
PDF file
MAMuneera Altaweel
Muneera Altaweel
EAELBADRI Ibrahim Abdelgadir
ELBADRI Ibrahim Abdelgadir
Shahinaz Faisal Bashir Bashir MohamedShahinaz Faisal Bashir Bashir Mohamed
Shahinaz Faisal Bashir Bashir Mohamed
KKKhamis Khamees Obeid Khamees
Khamis Khamees Obeid Khamees
WGWaleed Gamil Gado
Waleed Gamil Gado
LTLulwah Al Turki
Lulwah Al Turki
Background: Admission-based risk stratification in acute decompensated heart failure (ADHF) remains challenging, particularly in cohorts enriched for cardiorenal syndrome type 1 (CRS1). B-type natriuretic peptide (BNP) is the most extensively validated admission biomarker in ADHF, yet its independent contribution alongside heart failure (HF) phenotype and serum albumin within a prespecified multivariable mortality prediction model has not been formally established in CRS-enriched populations. Methods: In a retrospective cohort of consecutive index ADHF admissions (N=220 complete cases) at a single center enriched for CRS1, we developed a prespecified multivariable logistic regression model to predict in-hospital death using: age, sex, HF phenotype (HFpEF/HFmrEF/HFrEF), systolic blood pressure (SBP), estimated glomerular filtration rate (eGFR), serum albumin, and log-transformed BNP [ln(BNP)]. Discrimination was assessed by the area under the receiver operating characteristic curve (AUC) with 200-iteration bootstrap optimism correction. Calibration was assessed across risk deciles, and clinical utility was evaluated by decision curve analysis. Reporting followed the TRIPOD statement. Results: Seventeen patients (7.7%) died during the index hospitalization. ln(BNP) was the sole statistically significant independent predictor of in-hospital mortality (OR 2.39 per ln-unit; 95% CI 1.25–4.59; p=0.009). Albumin and eGFR showed consistent directional associations with mortality. The model demonstrated good apparent discrimination (AUC 0.81), with an optimism-corrected AUC of 0.73. Decision curve analysis indicated net benefit at threshold probabilities of 5–30%. A prespecified two-variable sensitivity model (albumin + ln[BNP]) yielded AUC 0.77, confirming the robustness of these two markers. Conclusions: This exploratory, internally validated model incorporating BNP, albumin, eGFR, and HF phenotype demonstrated promising discrimination for in-hospital mortality in a CRS-enriched ADHF cohort. The principal contribution is the application of a formally prespecified, TRIPOD-reported admission model in a CRS-enriched population, rather than identifying BNP as a novel prognostic marker. ln(BNP) was the sole statistically significant independent predictor. These findings are hypothesis-generating and require external validation before any clinical deployment.

Verified
Journal Article
Open access
PDF file
MAMuneera Altaweel
Muneera Altaweel
EAELBADRI Ibrahim Abdelgadir
ELBADRI Ibrahim Abdelgadir
Shahinaz Faisal Bashir Bashir MohamedShahinaz Faisal Bashir Bashir Mohamed
Shahinaz Faisal Bashir Bashir Mohamed
KKKhamis Khamees Obeid Khamees
Khamis Khamees Obeid Khamees
WGWaleed Gamil Gado
Waleed Gamil Gado
LTLulwah Al Turki
Lulwah Al Turki
Background: Risk stratification for acute decompensated heart failure (ADHF) at admission remains clinically challenging, particularly in patients with concomitant renal dysfunction. Although B-type natriuretic peptide (BNP) is a well-established biomarker in ADHF, its prognostic dominance in prespecified multivariable analyses of cohorts with frequent cardiorenal dysfunction remains incompletely characterized. Methods: We conducted a single-center retrospective cohort study of 220 index admissions for ADHF. A prespecified multivariable logistic regression model was developed to estimate in-hospital mortality using admission variables, including age, sex, heart failure phenotype, systolic blood pressure, estimated glomerular filtration rate, serum albumin, and log-transformed BNP. Model performance was evaluated using discrimination (AUC), bootstrap optimism correction (200 iterations), calibration assessment, and decision curve analysis, in accordance with the TRIPOD guidelines. Results: In-hospital mortality occurred in 7.7% of patients (n = 17). In multivariable analysis, ln(BNP) was the only variable that reached statistical significance as an independent predictor of in-hospital mortality (OR 2.39 per unit increase; 95% CI 1.25–4.59; p = 0.009), representing the dominant prognostic signal in this dataset. Albumin and eGFR showed consistent but non-significant associations. The exploratory model demonstrated apparent discrimination (AUC 0.81), which decreased to 0.73 after optimism correction. A prespecified simplified model including albumin and ln(BNP) yielded an AUC of 0.77. Conclusions: In this exploratory multivariable analysis, admission BNP emerged as the primary prognostic factor for in-hospital mortality in an ADHF cohort with a high prevalence of renal dysfunction. The small number of outcome events limits confidence in model stability and precludes clinical deployment. These findings are hypothesis-generating and support BNP as the strongest prognostic signal observed in this cohort. External validation in larger cohorts is required before any clinical application.